Immune reconstitution inflammatory syndrome in human immunodeficiency virus-infected children in Peru

Pediatric Infectious Disease Journal

Volumn 28, Issue 10, 2009, Pages 900-903

  Wang, Marie E ^a   Castillo, Maria E ^b   Montano, Silvia M ^c   Zunt, Joseph R ^d  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^c California   (Peru)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

AIDS; Children; HAART; HIV; Immune reconstitution inflammatory syndrome

Indexed keywords

ACICLOVIR; ANTIRETROVIRUS AGENT; DIDANOSINE; LAMIVUDINE; NELFINAVIR; STAVUDINE; TUBERCULOSTATIC AGENT; ZIDOVUDINE;

ARTICLE; CHILD; COHORT ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HERPES LABIALIS; HERPES ZOSTER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INCIDENCE; INFANT; LYMPHADENITIS; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MEDICAL RECORD REVIEW; MYCOBACTERIUM TUBERCULOSIS; NUTRITIONAL ASSESSMENT; PATHOGENESIS; PERU; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; TERTIARY HEALTH CARE; TREATMENT DURATION; TUBERCULOSIS; VARICELLA ZOSTER VIRUS; VIROLOGY; VIRUS LOAD;

EID: 70349664779     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181a4b7fa     Document Type: Article

References (24)

1. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338: 853-860.
2. French MA, Lenzo N, John M, et al. Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy. HIV Med. 2000;1:107-115.
3. Ratnam I, Chiu C, Kandala NB, et al. Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort. Clin Infect Dis. 2006;42:418-427.
4. Murdoch DM, Venter WD, Van Rie A, et al. Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options. AIDS Res Ther. 2007;4:9.
5. Boulware D, Callens S, Pahwa S. Pediatric HIV immune reconstitution inflammatory syndrome. Curr Opin HIV AIDS. 2008;3:461-467.
6. French MA, Price P, Stone SF. Immune restoration disease after antiretroviral therapy. AIDS. 2004;18:1615-1627.
7. Shelburne SA, Montes M, Hamill RJ. Immune reconstitution inflammatory syndrome: more answers, more questions. J Antimicrob Chemother. 2006; 57:167-170.
8. Meintjes G, Lawn SD, Scano F, et al. Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resourcelimited settings. Lancet Infect Dis. 2008;8:516-523.
9. Jevtovic DJ, Salemovic D, Ranin J, et al. The prevalence and risk of immune restoration disease in HIV-infected patients treated with highly active antiretroviral therapy. HIV Med. 2005;6:140-143.
10. Shelburne SA, Visnegarwala F, Darcourt J, et al. Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS. 2005;19:399-406.
11. Murdoch DM, Venter WD, Feldman C, et al. Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective study. AIDS. 2008;22:601-610.
12. Tangsinmankong N, Kamchaisatian W, Lujan-Zilbermann J, et al. Varicella zoster as a manifestation of immune restoration disease in HIV-infected children. J Allergy Clin Immunol. 2004;113:742-746.
13. Puthanakit T, Oberdorfer P, Akarathum N, et al. Immune reconstitution syndrome after highly active antiretroviral therapy in human immunodeficiency virus-infected Thai children. Pediatr Infect Dis J. 2006;25:53-58.
14. Steenhoff AP, Wood SM, Shah SS, et al. Cutaneous Mycobacterium avium complex infection as a manifestation of the immune reconstitution syndrome in a human immunodeficiency virus-infected child. Pediatr Infect Dis J. 2007;26:755-757.
15. Viani RM. Sarcoidosis and interstitial nephritis in a child with acquired immunodeficiency syndrome: implications of immune reconstitution syndrome with an indinavir-based regimen. Pediatr Infect Dis J. 2002;21:435-438.
16. Centers for Disease Control and Prevention. Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR. 1994;43.
17. International Network of the Study of HIV-associated IRIS. Case definition: consensus criteria for diagnosis of pediatric TB IRIS 2008. Available at: http://www.inshi.umn.edu/inshi/definitions/Peds-TB-IRIS.html. Accessed October 11, 2008.
18. de Onis M, Onyango A, Borghi E, et al. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ. 2007;85:661-668.
19. Zampoli M, Kilborn T, Eley B. Tuberculosis during early antiretroviralinduced immune reconstitution in HIV-infected children. Int J Tuberc Lung Dis. 2007;11:417-423.
20. Bakeera-Kitaka S, Dhabangi A, Namulema E. Immune reconstitution inflammatory syndrome and post-antiretroviral tuberculosis among HIVinfected Ugandan children-abstract . In: Infectious Diseases Society of America Annual Conference; 4-7 October, 2007; San Diego, CA.
21. Beisel WR. Nutrition in pediatric HIV infection: setting the research agenda. Nutrition and immune function: overview. J Nutr. 1996;126: 2611S-2615S.
22. Murray MJ, Murray AB, Murray NJ, et al. Infections during severe primary undernutrition and subsequent refeeding: paradoxical findings. Aust NZ J Med. 1995;25:507-511.
23. French MA. HIV/AIDS: immune reconstitution inflammatory syndrome: a reappraisal. Clin Infect Dis. 2009;48:101-107.
24. Bonham S, Meya DB, Bohjanen PR, et al. Biomarkers of HIV immune reconstitution inflammatory syndrome. Biomark Med. 2008;2:349-361.